Stocksigma LogoStocksigma Logo

Aspira Pathlab Reports Q2 Standalone Loss as Revenue Declines YoY

Aspira Pathlab & Diagnostics reported a net loss of ₹115.95 lakh for Q2 ended 30th Sep'26, down sharply from a net profit of ₹183.54 lakh in Q2 ended 30th

Aspira Pathlab Reports Q2 Standalone Loss as Revenue Declines YoY

Aspira Pathlab & Diagnostics Ltd · Financial Result · 06 Nov 2026, 10:20 pm

Aspira Pathlab Reports Q2 Standalone Loss as Revenue Declines YoY Aspira Pathlab & Diagnostics reported a net loss of ₹115.95 lakh for Q2 ended 30th Sep'26, down sharply from a net profit of ₹183.54 lakh in Q2 ended 30th Sep'25, with diluted EPS falling to ₹(1.13). Revenue from operations declined 22.63% YoY to ₹626.04 lakh compared to ₹809.28 lakh. For the half-year ended 30th Sep'26, the company posted a net loss of ₹119.72 lakh versus a profit of ₹230.49 lakh in the corresponding prior period, on revenue of ₹1,242.94 lakh.

Original exchange filing (PDF)

More announcements from Aspira Pathlab & Diagnostics Ltd

All Aspira Pathlab & Diagnostics Ltd announcements